Blood markers of ageing measured by a simple blood test
Blood markers of ageing now hold a central place in longevity medicine, as the "Gerodiagnostics" session of the Healthy Longevity 2026 intensive course in Singapore pointed out. The idea is simple but powerful: our biological age, more reliable than the age written on our ID card, can be read in part in our blood. Some biological clocks, such as PhenoAge described by Levine (Aging, 2018), combine just nine parameters from a standard blood test to estimate the body's real age.
PhenoAge: nine parameters to estimate biological age
Faced with more than 160 theoretically relevant markers that are hard to use in clinical practice, PhenoAge retains nine accessible values: RDW, blood glucose, CRP, chronological age, white blood cells, albumin, MCV, lymphocyte percentage, creatinine and alkaline phosphatase. The work of Fong (Nature Aging, 2024) confirms that this biological age predicts mortality and physical capacity better than chronological age. People who are biologically younger have lower mortality. Notably, CRP features in every blood clock compared (PCAge, LinAge, SenoClock, PhenoAge).
CRP, a reflection of chronic inflammation
CRP (C-reactive protein) reflects both infection and chronic low-grade inflammation, a recognised driver of ageing. A meta-analysis by Li (Atherosclerosis, 2017), covering 83,995 participants from 14 studies, is telling: a CRP above 3 mg/L, compared with a value below 1 mg/L, is associated with excess all-cause mortality (RR 1.75), cardiovascular mortality (RR 2.03) and cancer mortality (RR 1.25).
These findings hold at all ages. Among heart attack survivors in Stockholm (Carrero, JAHA 2019, 17,464 patients), the relationship between CRP and mortality remains linear up to about 5 mg/L. And even in the very elderly, with a median age of 93 (Chen, Frontiers in Public Health 2022), a high CRP still increases the risk of death (HR up to 1.49). Inflammation therefore remains a relevant marker into very old age.
RDW, an underrated haematological index
RDW measures the variation in the size of red blood cells. Long overlooked, it has proven to be a powerful predictor of mortality. According to Perlstein (JAMA Internal Medicine, 2009, 15,852 American adults), each 1% increase in RDW is accompanied by a 23% increase in all-cause mortality. Patel (Archives of Internal Medicine, 2010) confirms this figure in 8,175 people over 45, with 22% excess mortality per point. A routine parameter of a blood count thus becomes a signal of biological ageing.
HbA1c, the memory of blood sugar
HbA1c (glycated haemoglobin) reflects average blood glucose over the previous three months. The work of Selvin (New England Journal of Medicine, 2010, 11,092 non-diabetic subjects followed for 14 years) shows a J-shaped relationship with all-cause mortality, and a 16-fold higher risk of diabetes above 6.5%. The meta-analysis by Cavero-Redondo (BMJ Open, 2017, 46 studies) places the lowest mortality between 5.0 and 6.0% in non-diabetics. A key lesson from Singapore: "optimal" longevity values are narrower than laboratory values that are simply "normal".
Normal does not mean optimal
In summary, blood markers of ageing remain the reference for biological clocks today: inflammatory (CRP, IL-6), metabolic (HbA1c) and haematological (RDW). Their strength lies in their accessibility, since a routine blood test is enough. But the essential point lies in nuance: aiming for optimal ranges, defined by large epidemiological studies, rather than settling for a result within the norm. This fine-grained reading, combined with lifestyle, paves the way for personalised prevention of ageing.



